News

A new ISHLT Document, ISHLT Consensus Statement on the Referral and Selection of Pediatric Lung Transplant Candidates, has been published in JHLT and is available to read online.

The ISHLT2026 Call for Abstracts submission site closes next week. Don’t delay – submit your best science in advanced heart and lung failure and transplantation, mechanical circulatory support, and pulmonary vascular disease by Tuesday, 14 October at 11:59 p.m. ET/Wednesday, 15 October at 03:59 UTC.

ISHLT will host a joint educational workshop, Current Status of Heart and Lung Allocation, with the Associação Brasileira de Transplantes de Órgãos (ABTO) at the Pre-Congress of their 2025 Annual Congress.

Next month, a webinar from Natera will bring together leading transplant experts to unveil the latest findings from the DEFINE-HT study and explore the clinical utility of donor-derived cell-free DNA with Donor Quantity Score in heart transplantation.

In response to the Organ Procurement and Transplantation Network (OPTN) annual summer call for public comments, the ISHLT has submitted official comments on four OPTN proposals.

Dr. Ayumi Goda of Kyorin University Hospital in Tokyo appears on JHLT: The Podcast to discuss her team's study on unmasking occult HFpEF in pulmonary hypertension patients.

In September's ISHLT Journal Watch, cardiothoracic surgeons review recent literature on DCD heart transplant, lung transplant, and xenotransplantation.

Per the ISHLT Bylaws and Policies, the ISHLT Board of Directors has approved the slate of Directors and Officers for election as presented by the Governance Nominating Committee. This slate is now presented for a vote of ISHLT members.

Applications for exhibit space and support opportunities at the ISHLT Annual Meeting are now open. ISHLT2026 is the largest, most influential interdisciplinary gathering for healthcare and allied professionals in advanced heart and lung disease.

CMV Stream 2025, brought to you by Kamada, features leading voices in transplantation for a dynamic, live expert panel discussion on “CMV Management in Solid Organ Transplantation: Insights and Challenges from the 4th International Consensus Guidelines on the Management of CMV in Solid Organ Transplantation”.

The ISHLT’s Advanced Heart Failure and Transplantation Interdisciplinary Network and the International Cardio-Oncology Society (ICOS) present a joint webinar, Crossroads of Care - Cardio-Oncology After Heart Transplant and Durable LVAD. Register now to join on 29 October.

Watch this video to learn more about the latest in pulmonary vascular disease topics that were discussed at ISHLT2025 in Boston this April.

ISHLT is pleased to welcome Nikki Shanks, MBA, CAE as Director of Member Engagement and Governance. In this role, Nikki will lead the Society’s efforts to grow and engage its global membership while ensuring effective support for governance operations.

The deadline for current ISHLT funding opportunities is quickly approaching. Applications for three industry-supported research grants (funded through the ISHLT Foundation) and the new International Visiting Scholarship will close on Tuesday, 30 September at 11:59 p.m. ET / Wednesday, 1 October at 03:59 UTC.

Watch this video to learn more about the latest in mechanical circulatory topics that were discussed at ISHLT2025 in Boston this April.

A new ISHLT Document, ISHLT Consensus Document on Risk Stratification in Pulmonary Arterial Hypertension, has been published in JHLT and is available to read online.

Ahmet Bilgili and Eric Jeng, MD, of the University of Florida, are on JHLT the Podcast to discuss optimal pre-transplant duration for HeartMate III LVADs.

It's time to renew your ISHLT membership for 2026. The Society welcomes you back for another year of advancing the science and standards of care for advanced heart and lung disease. And this year, ISHLT has reduced dues for Trainee members by up to 70%, removing barriers to participation and investing in the future of our field.

The ISHLT has released a statement regarding the role of vaccines in protecting the health and survival of heart and lung transplant candidates and recipients. The statement was developed by ISHLT members in transplantation, infectious disease, and pediatrics.

The ISHLT ACHD-HF Special Interest Group is open to all ISHLT members with a special interest in adult congenital heart disease and heart failure.